Accès ouvert
2023
other
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Abstract Despite substantial advances in the treatment of solid cancers, resistance to therapy remains a major obstacle to prolonged progression-free survival. Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, with a high level of liver metastasis. Primary PDAC is …
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Data from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Accès ouvert
2023
supplementary-materials
OpenAlex
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres
Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment